Clinical Trials Logo

Dysmenorrhea clinical trials

View clinical trials related to Dysmenorrhea.

Filter by:

NCT ID: NCT05938660 Active, not recruiting - Clinical trials for Primary Dysmenorrhea

Effects of Acupressure at Sanyinjiao Point on Primary Dysmenorrhea Among University Students.

Start date: November 22, 2022
Phase: N/A
Study type: Interventional

The goal of this non-invasive interventional study is to explore the university students' experience of living with primary dysmenorrhea and evaluate the effect of acupuncture at the Sanyinjiao point on their physiological discomfort. The main questions it aims to answer are: - Is there any difference in pain before and after the intervention of the Sanyinjiao point acupressure for dysmenorrhea among female college students? - Is there any difference in the average number of Menstrual Distress Questionnaire scale before and after Sanyinjiao acupressure in female college students with dysmenorrhea? Participants will be acupressure at Sanyinjiao point triple times during the study.

NCT ID: NCT05909956 Completed - Clinical trials for Primary Dysmenorrhea

Effects of Therapeutic Tapping in Primary Dysmenorrhea

Start date: June 7, 2023
Phase: N/A
Study type: Interventional

Dysmenorrhea is more common among women of reproductive age, as it affects their quality of life and limit their daily activities and normal functioning. The estimates of dysmenorrhea from research conducted all around the world varied widely, from 20% to 90%. This study is planned to determine the effects of KT on clinical symptoms, QOL and academic performance of students with Primary dysmenorrhea.

NCT ID: NCT05900336 Recruiting - Dysmenorrhea Clinical Trials

Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea

Start date: March 25, 2024
Phase: Phase 4
Study type: Interventional

Menstrual pain is the most common gynecological complaint and the leading cause of school and work absences in reproductive-age girls and women. One of the primary treatments for menstrual pain is use of nonsteroidal anti-inflammatory drugs (NSAIDs; over-the-counter medications such as naproxen, ibuprofen, or aspirin), although up to 18% of women do not get pain relief from these medications. One reason for this may be due to central sensitization of pain, which is when alterations in the central nervous system change how pain is processed in the brain and experienced. Determining the role of central sensitization in menstrual pain is important because central sensitization is associated with the development of chronic pain. Understanding the relationship between NSAID response and central sensitization is important because it could indicate women who may go on to develop chronic pain later in life. This study would directly address this question. Identifying women at risk for chronic pain would help target new treatments to this vulnerable group to ideally prevent pain from becoming chronic. This is particularly important for women in the military because the severity of menstrual pain is associated with missed work, such that in active-duty military women, less than 4.4% with mild menstrual pain missed work, whereas 20.7% of women with moderate to severe menstrual pain missed work. Addressing the significant impact of menstrual pain for military women will help reducing suffering and potentially decrease the risk of developing future chronic pain problems in this population.

NCT ID: NCT05885945 Completed - Clinical trials for Dysmenorrhea Primary

Diaphragmmatic Muscle Strength and Balance in Women With Dysmenorhea

Dysmenorhea
Start date: February 15, 2023
Phase:
Study type: Observational

Analysis of stabilometric and respiratory variables in patients with dysmenorrhea during the first day of the menstrual cycle and any other day outside the cycle.

NCT ID: NCT05845970 Completed - Clinical trials for Premenstrual Syndrome

An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief

Start date: February 8, 2023
Phase: Phase 1
Study type: Interventional

Women often experience significant pain during their periods which can significantly impact on quality of life. In this study, two products that are used to alleviate period pain will be examined. One test product is botanically based, and the other is a traditional over-the-counter pain reliever with additional components added to support less painful periods. The trial will be a cross-over trial where participants will use the botanical product before, during, and after their first period. Participants will use the botanical product alongside a traditional over-the-counter period product during their second period. Participants will answer surveys and have blood drawn at a third-party lab to answer the main objectives of this trial.

NCT ID: NCT05829512 Recruiting - Dysmenorrhea Clinical Trials

Translation, Reliability, and Validity of Turkish Version of the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) Score

Start date: April 1, 2023
Phase:
Study type: Observational

Currently, there is no agreement in the use of standard questionnaires with adequate validation and structuring measures to classify the severity of dysmenorrhea. This may explain the variability in prevalence, conditions associated with absenteeism (work, school, etc.), or errors in the diagnostic approach to patients with pelvic pain. The aim of this study is to conduct a cross-cultural adaptation study of the Turkish version of the working ability, location, intensity, days of pain, dysmenorrhea (WaLIDD) score, a tool designed to allow the identification of women with dysmenorrhea and those at high risk of obtaining medical clearance for the general population.

NCT ID: NCT05817513 Recruiting - Quality of Life Clinical Trials

EFFECT OF MYOFASCIAL RELEASE ON SCOLIOTIC CURVATURE AND PREMENSTRUAL SYMPTOMS IN FEMALES WITH DYSMENORRHEA

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

PURPOSE: The purpose of this study is to determine the effect of myofascial release on spinal curvature, premenstrual symptoms, and quality of life in scoliotic females with dysmenorrhea

NCT ID: NCT05815654 Recruiting - Dysmenorrhea Clinical Trials

Research and Development of WPAPS Based on the Modern Technology of Traditional Chinese Medicine

Start date: December 20, 2022
Phase: N/A
Study type: Interventional

The goal of this double-blind randomized controlled trial is to determine the efficacy of Warm Palace Analgesic Point Sticker in relieving dysmenorrhea compared to placebo sticker. The main questions it aims to answer are: - Can this Warm Palace Analgesic Point Sticker relieve dysmenorrhea? - It is more effective to certain type of TCM syndrome differentiation? Qi stagnation and blood stasis syndrome or cold dampness syndrome? Participants will : - receive test sticker or control sticker five days before every menstruation, once a day, five hours each time, for five consecutive days - take pictures of tongue - fill in some questionnaires after treatment

NCT ID: NCT05810116 Recruiting - Menstrual Pain Clinical Trials

Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain

Start date: May 19, 2023
Phase: Phase 4
Study type: Interventional

This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Palmitoylethanolamide (PEA) compared to placebo on menstrual pain in otherwise healthy participants 18 years and over.

NCT ID: NCT05799924 Recruiting - Dysmenorrhea Clinical Trials

The Study on the Therapeutic Effect and Mechanism of Transcutaneous Acupoint Electrical Stimulation in Female

Start date: February 21, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the use of TEAS on female patients with dysmenorrhea. The main questions it aims to answer are: Questions 1:Effect of TEAS on dysmenorrhea Questions 2:Mechanism of TEAS in treatment of dysmenorrhea Participants will wear TEAS devices to treat dysmenorrhea during menstruation The participants in the control group were treated with oral medication for dysmenorrhea